SGMO icon

Sangamo Therapeutics
SGMO

Overview Fund Activity

193 hedge funds and large institutions have $657M invested in Sangamo Therapeutics in 2019 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 56 increasing their positions, 56 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
193
Holders Change
+9
Holders Change %
+4.89%
% of All Funds
3.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
56
Reduced
56
Closed
18
Calls
$10.5M
Puts
$13.4M
Net Calls
-$2.85M
Net Calls Change
-$5.66M

Top Buyers

1
PAMU
Pictet Asset Management (UK)
United Kingdom
$11.3M
2
WA
Wasatch Advisors
Utah
$62.7M
3
Creative Planning
Creative Planning
Kansas
$3.67M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
$3.33M
5
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$7.95M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
$64.8M
2
Citadel Advisors
Citadel Advisors
Florida
$8.08M
3
MWNA
Marshall Wace North America
New York
$263K
4
Jennison Associates
Jennison Associates
New York
$0
5
Fidelity Investments
Fidelity Investments
Massachusetts
$16.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
SG Americas Securities
201
SG Americas Securities
New York
– -$155K -17,138 Closed
RJFSA
202
Raymond James Financial Services Advisors
Florida
– -$109K -12,080 Closed
PCM
203
Princeton Capital Management
New Jersey
– -$57K -6,350 Closed
ASN
204
Advisory Services Network
Georgia
– -$67K -6,267 Closed
TJHA
205
Thomas J. Herzfeld Advisors
Florida
– -$45K -5,000 Closed
NCM
206
Nelson Capital Management
California
– -$9K -1,000 Closed
AIC
207
Ameritas Investment Company
Nebraska
– -$5K -500 Closed
LC
208
Lindbrook Capital
California
– -$1K -150 Closed
5 6 7 8
9